- Home
- IGC vs SPAI Comparison
IGC vs SPAI Comparison
Compare IGC & SPAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IGC
- SPAI
- Stock Information
- Founded
- IGC 2005
- SPAI 2021
- Country
- IGC United States
- SPAI United States
- Employees
- IGC N/A
- SPAI N/A
- Industry
- IGC Biotechnology: Pharmaceutical Preparations
- SPAI Industrial Specialties
- Sector
- IGC Health Care
- SPAI Health Care
- Exchange
- IGC Nasdaq
- SPAI Nasdaq
- Market Cap
- IGC 26.9M
- SPAI 27.1M
- IPO Year
- IGC N/A
- SPAI 2024
- Fundamental
- Price
- IGC $0.35
- SPAI $4.47
- Analyst Decision
- IGC Strong Buy
- SPAI
- Analyst Count
- IGC 2
- SPAI 0
- Target Price
- IGC $3.63
- SPAI N/A
- AVG Volume (30 Days)
- IGC 222.5K
- SPAI 4.7M
- Earning Date
- IGC 11-12-2024
- SPAI 11-14-2024
- Dividend Yield
- IGC N/A
- SPAI N/A
- EPS Growth
- IGC N/A
- SPAI N/A
- EPS
- IGC N/A
- SPAI N/A
- Revenue
- IGC $1,183,000.00
- SPAI $1,559,057.00
- Revenue This Year
- IGC N/A
- SPAI N/A
- Revenue Next Year
- IGC $13.57
- SPAI N/A
- P/E Ratio
- IGC N/A
- SPAI N/A
- Revenue Growth
- IGC N/A
- SPAI 35.50
- 52 Week Low
- IGC $0.25
- SPAI $1.56
- 52 Week High
- IGC $0.91
- SPAI $6.50
- Technical
- Relative Strength Index (RSI)
- IGC 42.76
- SPAI N/A
- Support Level
- IGC $0.33
- SPAI N/A
- Resistance Level
- IGC $0.42
- SPAI N/A
- Average True Range (ATR)
- IGC 0.02
- SPAI 0.00
- MACD
- IGC -0.00
- SPAI 0.00
- Stochastic Oscillator
- IGC 32.14
- SPAI 0.00
About IGC IGC Pharma Inc.
IGC Pharma Inc develops advanced cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease, IGC-AD1 and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles. IGC-AD1 is a low-dose tetrahydrocannabinol-based formulation that is in a 146-person Phase 2 clinical trial for agitation in dementia due to Alzheimer's. IGC also markets a wellness brand, Holief, that targets women experiencing premenstrual syndrome and menstrual cramps.
About SPAI Safe Pro Group Inc. Common Stock
Safe Pro Group Inc operates to acquire security and protection products. Its emphasis is on the development of a cloud-based ecosystem for analyzing drone imagery and data utilizing proprietary artificial intelligence (AI), machine learning, deep learning, and applied computer vision software for hyper scalable processing, analysis, and reporting. The company operated in three reportable business segments which consisted of: the business of Safe-Pro USA, the business of Airborne Response, and the business of Safe Pro AI. Key revenue is generated from Safe-Pro USA.